Drew et al. verified that reduced ERα expression in AT was associated with breast cancer proliferation and migration by increasing adipocyte-specific Lcn2 production and enhancing Lcn2 sensitivity of breast cancer cells [114]. The gene discussed is LCN2; the disease is breast carcinoma.